Annual Meeting
You must register to attend our virtual meeting.
Date: June 10, 2026
Time: 12:00 PM ET
View an enhanced version of our Annual Report.
View an enhanced version of our Notice of Meeting & Proxy Statement.
Your vote is IMPORTANT!
Please vote your proxy online now or by phone by dialing 866-390-6228.
You must register to attend our virtual meeting.
Date: June 10, 2026
Time: 12:00 PM ET
BioAge is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases by targeting the biology of human aging. The company’s pipeline includes novel, orally available, brain-penetrant small-molecule NLRP3 inhibitors to treat metabolic diseases and conditions driven by neuroinflammation, as well as novel, structurally differentiated APJ agonists for metabolic disorders. BioAge’s additional preclinical programs, which leverage insights from the Company’s proprietary discovery platform built on human longevity data, address key pathways involved in metabolic aging.